169356 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors; Neurotransmitters GABA, i.e. gamma-amino-butyrate
FLEXIBLE MOLECULARLY IMPRINTED SENSOR FOR IN-SITU AND IN-VIVO DETECTION OF GAMMA-AMINOBUTYRIC ACID CONTENT IN PLANTS, AND PREPARATION METHOD AND DETECTION METHOD THEREOF
#2GENETICALLY ENCODED BIOLUMINESCENT SENSORS
#3METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS
#4Method for simultaneous analysis of neurotransmitters and their metabolites based on derivatization
#5Methods of selecting subjects for treatment with metabolomic modulators
#6METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS
#7POSITIVE ALLOSTERIC MODULATORS OF GABA A RECEPTOR
#8Rapid and sensitive method of forensic toxicology in post-mortem subjects and in live and post-mortem animals using oral fluid testing
#9Reducing memory loss in mammals suffering from Alzheimer's disease
#10METHODS AND APPARATUS FOR DETECTING COMPOUNDS IN LIQUIDS
#11Metabolic biomarkers of autism
#12Medical use of artemisinin compounds and gephyrin agonists
#13Methods for detecting autoantibodies against a GABA(A) receptor alpha 1 subunit and/or beta 3 subunit in autoimmune seizure and/or encephalitis
#14Reducing memory loss in mammals suffering from alzheimer's disease
#15CELL LINES AND METHODS FOR MAKING AND USING THEM
#16IMMUNOASSAY FOR PREGABALIN
#17Double caged GABA compounds, bis-CNB-GABA
#18Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
#19PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE AND METHOD OF SCREENING THE SAME
#20GABA release-regulating agent in cerebellum
#21Molecule biomarkers of autism
#22Method for detecting compounds modulating dimers of VFT domain membrane proteins
#23Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome
#24RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies
#25CELL LINES EXPRESSING GABA RECEPTOR AND METHODS USING THEM
#26CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended)
#27GABA neuron progenitor cell marker 65B13
#28Methods and Tools for The Therapy of Neurodegenerative Pathologies
#29Methods and compositions related to GABA receptor subunits
#30Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability
#31RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies
#32Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca influx in cells
#33Nanoscale Neuromodulating Platform For Retina Neuron Activation Apparatus and Method
#34Agents for therapy efficacy monitoring and deep tissue imaging
#35Pyrazolylmethy Heteroaryl Derivatives
#36Screening of compounds for OCTN2 transporter activity
#37Screening of compounds for BGT1 transporter activity
#38Method for separating precursor cells producing gabaergic neuron alone
#39Screening of compounds for GAT2 transporter activity
#40αβδGABA-A receptors as a strategy for PMS and alcoholism
#41Use of gabaa receptor agonists for the treatment of hearing, vestibular and attention disorders, intention tremor and restless leg syndrome
#42Novel receptor
#43Chimeric gaba receptor
#44GABA detection methods and applications
#45Nematode neuromuscular junction GABA receptors and methods related thereto
#46Method for measuring ion channel activity
#47Method for screening for compounds as potential sedatives or anxiolytics
#48Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca2+ influx in cells
#49Acoustic immunosensor for detecting neurotransmitter GABA
#50Selective anesthetic agents and methods of identifying the same
#51Electrochemical micro-sensor for GABA detection